Recurrent Adult Soft Tissue Sarcoma Completed Phase 2 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00937495Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue SarcomaTreatment